Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 149

Esri absorbs nFrames

Vector Venture Capital has exited nFrames, a developer of 3D surface reconstruction software that has been bought by Esri for an undisclosed amount.

Sep 14, 2020

Codiak comes back for second IPO attempt

Exosome therapy developer Codiak Biosciences – based on research at Gothenburg and MD Anderson Cancer Center – has filed to raise up to $100m.

Sep 11, 2020

Codiak comes back for second IPO attempt

Alexandria Real Estate Equities-backed exosome therapy developer Codiak Biosciences has filed to raise up to $100m having pulled back from an earlier offering last year.

Sep 11, 2020

PolyTech pulls in Fos4X

Equinor has exited wind power technology provider Fos4X in an acquisition by PolyTech that followed at least $12.5m in venture funding.

Sep 11, 2020

PolyTech picks up Fos4X

TU Munich's wind farm IoT spinout Fos4X has been acquired by PolyTech, providing an exit tothe university's venture capital affiliate UVC Partners.

Sep 11, 2020

NinthDecimal gets Kiip in acquisition deal

American Express, Interpublic, US Cellular and Verizon exited the advertising platform developer last year in an acquisition by NinthDecimal.

Sep 10, 2020

Omnitracs to take SmartDrive in $450m deal

Stanford University is set to exit video telematics system developer SmartDrive, which has agreed to be purchased after raising at least $265m.

Sep 10, 2020

3Peak seeks $339m in IPO

Huawei’s venture capital arm Hubble Technologies is in line for an exit less than nine months after it invested in fabless semiconductor maker 3Peak.

Sep 10, 2020

DCG loops back for Luno acquisition

Naspers and Rand Merchant Investment both exited digital asset marketplace and wallet Luno, which has been bought by fellow investor Digital Currency Group.

Sep 10, 2020

PMV veers toward $100m IPO

PMV Pharmaceuticals – built on foundational work at Princeton – will use some of the proceeds to complete phase 1 trials of its lead asset.

Sep 10, 2020
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here